4
Changes in Ownership
PALISADE BIO, INC. Filed Acc 0001493152-22-023511
Chief Executive Officer bought 40,000 shares at $0.25 ($10,000)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hallam Thomas Chief Executive Officer | 2022-08-16 | Purchase | +40,000 | $0.25 | $10,000 | 57,592 | D: show line 1 in the form |
| Open-market purchases · 40,000 sh · avg $0.25 · $10,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Hallam Thomas Chief Executive Officer | 2022-08-16 | Purchase · Series 1 Common Stock Purchase Warrant | +40,000 | 40,000 | D: show line 2 in the form | |||||
| Hallam Thomas Chief Executive Officer | 2022-08-16 | Purchase · Series 2 Common Stock Purchase Warrant | +40,000 | 40,000 | D: show line 3 in the form |
Loading xslF345X03/ownership.xml…